Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Camp4 Therapeutics (CAMP) Capital Leases (2023 - 2025)

Camp4 Therapeutics' Capital Leases history spans 3 years, with the latest figure at $47000.0 for Q3 2025.

  • For Q3 2025, Capital Leases fell 45.98% year-over-year to $47000.0; the TTM value through Sep 2025 reached $47000.0, down 45.98%, while the annual FY2024 figure was $70000.0, 52.7% down from the prior year.
  • Capital Leases for Q3 2025 was $47000.0 at Camp4 Therapeutics, down from $59000.0 in the prior quarter.
  • Across five years, Capital Leases topped out at $148000.0 in Q4 2023 and bottomed at $47000.0 in Q3 2025.
  • The 3-year median for Capital Leases is $64500.0 (2024), against an average of $78166.7.
  • The largest annual shift saw Capital Leases plummeted 52.7% in 2024 before it crashed 45.98% in 2025.
  • A 3-year view of Capital Leases shows it stood at $148000.0 in 2023, then tumbled by 52.7% to $70000.0 in 2024, then crashed by 32.86% to $47000.0 in 2025.
  • Per Business Quant, the three most recent readings for CAMP's Capital Leases are $47000.0 (Q3 2025), $59000.0 (Q2 2025), and $58000.0 (Q1 2025).